EE9400346A - Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid - Google Patents

Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Info

Publication number
EE9400346A
EE9400346A EE9400346A EE9400346A EE9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A
Authority
EE
Estonia
Prior art keywords
galanin
pro
preparation process
pharmaceutical preparations
preparations containing
Prior art date
Application number
EE9400346A
Other languages
English (en)
Estonian (et)
Inventor
Bartfai Tamas
H�kfelt Tomas
Langel Ulo
Ahren Bo
Lindskog Stefan
Consolo Silvana
Land Tiit
Wiesenfeld-Hallin Zsuzsanna
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9400346A publication Critical patent/EE9400346A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9400346A 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid EE9400346A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101472A SE9101472D0 (sv) 1991-05-15 1991-05-15 Galanin antagonist

Publications (1)

Publication Number Publication Date
EE9400346A true EE9400346A (et) 1996-04-15

Family

ID=20382742

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400346A EE9400346A (et) 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Country Status (24)

Country Link
EP (2) EP0585300B1 (de)
JP (1) JPH06507629A (de)
KR (1) KR100221769B1 (de)
AT (1) ATE149525T1 (de)
AU (1) AU664180B2 (de)
CA (1) CA2109503A1 (de)
CZ (1) CZ242293A3 (de)
DE (2) DE69217937T2 (de)
DK (1) DK0585300T3 (de)
EE (1) EE9400346A (de)
ES (1) ES2098510T3 (de)
FI (1) FI935010L (de)
GR (1) GR3023150T3 (de)
HU (1) HUT65810A (de)
IE (1) IE921555A1 (de)
IS (1) IS3866A (de)
NO (1) NO934098D0 (de)
PL (1) PL171497B1 (de)
SE (1) SE9101472D0 (de)
SG (1) SG43921A1 (de)
SI (1) SI9200081B (de)
SK (1) SK127793A3 (de)
WO (1) WO1992020709A1 (de)
YU (1) YU50592A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
FR2716205B1 (fr) 1994-02-17 1996-04-12 Rhone Poulenc Rorer Sa Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
US6790656B1 (en) 1996-01-24 2004-09-14 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR2 receptors
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
EP0918455B1 (de) 1996-07-24 2003-04-16 Neurotargets Limited Gebrauch von galanin um nervenschäden zu reparieren
US6329197B2 (en) 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
AU741546B2 (en) * 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
WO1999048920A1 (en) * 1998-03-25 1999-09-30 Takeda Chemical Industries, Ltd. Novel physiologically active peptides and utilization thereof
US6407136B1 (en) 1999-05-21 2002-06-18 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
WO2000071533A2 (en) * 1999-05-21 2000-11-30 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
EP1089439A1 (de) * 1999-09-28 2001-04-04 TELEFONAKTIEBOLAGET L M ERICSSON (publ) Verschachteler und Eingangsdatabitverschachtelungsverfahren unter Anwendung von symbolkodierter Speicherung und zusätzlichen Informationen
US7220775B2 (en) 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain
EP1809619A1 (de) 2004-10-21 2007-07-25 Transtech Pharma, Inc. Bisulfonamidverbindungen als agonisten von galr1, zusammensetzungen daraus und verwendungsmöglichkeiten dafür
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
KR20090009189A (ko) 2006-01-05 2009-01-22 유니버시티 오브 유타 리써치 파운데이션 신경계를 표적으로 하는 약제학적 제제의 특성 향상 방법및 특성 향상용 조성물
US20100204129A1 (en) * 2008-09-09 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
CN110055340B (zh) * 2019-04-11 2021-01-01 中国农业大学 一种食品中牛源成分快速检测方法及试剂盒

Also Published As

Publication number Publication date
FI935010A0 (fi) 1993-11-12
ATE149525T1 (de) 1997-03-15
IS3866A (is) 1992-11-16
CZ242293A3 (en) 1994-07-13
ES2098510T3 (es) 1997-05-01
EP0585300B1 (de) 1997-03-05
SE9101472D0 (sv) 1991-05-15
KR100221769B1 (ko) 1999-10-01
EP0514361A1 (de) 1992-11-19
HUT65810A (en) 1994-07-28
JPH06507629A (ja) 1994-09-01
YU50592A (sh) 1994-09-09
SI9200081B (sl) 2000-08-31
WO1992020709A1 (en) 1992-11-26
FI935010A7 (fi) 1993-11-12
CA2109503A1 (en) 1992-11-16
SG43921A1 (en) 1997-11-14
PL171497B1 (pl) 1997-05-30
SK127793A3 (en) 1994-04-06
DE69217937T2 (de) 1997-06-19
FI935010L (fi) 1993-11-12
AU664180B2 (en) 1995-11-09
DE69217937D1 (de) 1997-04-10
NO934098L (no) 1993-11-12
NO934098D0 (no) 1993-11-12
IE921555A1 (en) 1992-11-18
EP0585300A1 (de) 1994-03-09
GR3023150T3 (en) 1997-07-30
DE585300T1 (de) 1994-06-16
AU1785892A (en) 1992-12-30
DK0585300T3 (da) 1997-09-01
SI9200081A (en) 1992-12-31

Similar Documents

Publication Publication Date Title
ATE149525T1 (de) Galaninantagonist
FI910286A0 (fi) Analoger av humant insulin och preparat innehaollande dessa.
TW349867B (en) Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses
DE69028671D1 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
GB9317104D0 (en) Therapeutic heterocycles
EP1233013A4 (de) Phenylalaninderivate
NO871574L (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
FI916077A7 (fi) Glykosyloimattomia ihmisen interleukiini 3:n proteiinianalogeja
ES2059545T3 (es) Hormonas de glicoproteinas modificadas por mutagenesis dirigida por puntos y metodos de uso de tales hormonas.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
SE8800080D0 (sv) Lekemedelskomposition
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
EP0796867A4 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
FI900298A7 (fi) Substituoituja bentso (b) pyraaneja, menetelmiä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuvia farmaseuttisia valmisteita
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
RU2002121974A (ru) Способ подготовки производителей осетровых к нересту
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
IT1216535B (it) O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico.